Qu et al. found that NOVA1 is a novel oncogene that is able to activate Wnt/β-catenin signalling, which is one of the critical signalling pathways that regulates EMT, with a consequent increase in the proliferation and invasion of non-small-cell lung cancer (NSCLC). This evidence concerns the gene NOVA1 and non-small cell lung carcinoma.